Are Peptides Right for You? A Practical Guide for Patients

Peptides are everywhere in today’s health care headlines — from weight-loss medications to conversations about recovery, longevity and metabolic health. But what exactly are they, and how do they differ from traditional prescriptions or over-the-counter supplements?

As synthetic peptide medications gain popularity and telehealth expands access to treatment, patients are increasingly curious about what’s evidence-based, what’s still emerging and how to safely navigate their options. Understanding the science, safety profile and sourcing behind peptide therapies is critical to making informed decisions.

In an interview with The Educated Patient, Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, breaks down what peptides are, why they’re drawing attention in both medical and wellness circles, and the key questions patients should ask before considering peptide therapy.

What exactly are peptides, and how are they different from traditional medications or supplements?

Mark Mikhael: Peptides are short chains of amino acids that occur naturally in the body. You produce thousands of them on a regular basis. They act as signaling molecules, telling cells to do specific tasks, such as release hormones, regulate appetite, repair tissue and manage inflammation. What makes them different from traditional medications is precision. Many conventional drugs broadly stimulate or suppress a system. Peptides tend to bind to very specific receptors and trigger very targeted responses. With this in mind, they perform a different function from supplements as well. While supplements usually provide nutrients your body uses as raw material, peptides act more like instructions for your body, signaling it to change behavior.

Why are peptides getting so much attention right now in health care and wellness conversations?

MM: The two biggest reasons for peptides’ rise in popularity come down to results and visibility. When it comes to results, we’ve all seen the rise of GLP-1 medications like semaglutide. These medications are, in fact, synthetic peptides — that’s the “P” in “GLP.” When these started hitting the market, it showed the public that peptides could help make positive changes in the body in the areas of weight loss and metabolic improvement. That changed the perception of what these compounds can do. Second, we’re in an age where optimizing health is no longer solely motivated by addressing a disease state. With the rise of GLP-1s and many patients learning how to self-administer these medications, it opened the floodgates for patient at-home administration. Patients have new ways of finding care plans that center on better recovery, body composition and aging.

Peptides, being naturally occurring, have become an appealing option for those looking to put a bigger focus on their health. That spotlight on peptides has also been brought on by the inception of stronger telehealth access. A lot more power is now in the hands of patients, and they’re able to find options that fit their needs faster thanks to the rise of telemedicine. Being able to address medical needs and achieve stronger patient outcomes at home has made access to life-changing medications much easier. A lot of the fear and anxiety that comes with seeking out treatment diminishes when you can meet with a doctor from the comfort of your home.

What conditions are peptides currently approved to treat, and where is the research still emerging?

MM: Several peptides are fully U.S. Food and Drug Administration (FDA)-approved and well-studied. For example: GLP-1 receptor agonists for Type 2 diabetes and obesity, insulin for diabetes, growth hormone for specific deficiency states, just to name a few. Those have strong human data from various clinical trials. The research is still emerging in the areas of injury recovery, gut healing, antiaging and athletic performance. You’ll hear names like BPC-157 or various growth hormone secretagogues. The early data may be interesting, but these are still in the research phase. Many of these findings come from animal studies or small human trials. That doesn’t mean they won’t eventually prove useful; it just means we’re not there yet in terms of large-scale clinical evidence.

What should patients know about the safety profile of peptides? Are there common side effects or risks?

MM: The safety profile depends entirely on the peptide and the source. For FDA-approved peptides, we know the common side effects because they’ve been studied. For example, GLP-1 medications often cause nausea, slow digestion or appetite suppression. With unapproved peptides, the bigger risk is uncertainty. We don’t always know long-term safety data. Then there’s sourcing. Many third-party markets selling these unregulated peptides label them as “research use only,” navigating them through a legal loophole if a person is negatively affected by taking it. Alongside that, unregulated products can carry risks of contamination, incorrect dosing or mislabeling. That’s often the most overlooked danger. Some peptides are permitted by the FDA to be compounded at facilities like Olympia’s. These facilities undergo rigorous inspections to ensure they’re upholding current Good Manufacturing Practices, or cGMPs. They’re distinct from gray-market sellers in that FDA-registered facilities operate above board, only compounding and offering what the FDA gives them direct permission to. Patients should work together with their providers to verify sourcing for peptides.

Who might be a good candidate for peptide therapy — and who should avoid it?

MM: A good candidate is someone with a clearly defined medical issue that aligns with an approved peptide treatment: obesity, diabetes, hormone deficiency, certain endocrine conditions. It can also be appropriate for carefully selected patients working with experienced providers who are monitoring labs and outcomes. When used thoughtfully and with appropriate medical oversight, peptides can be integrated into a precision-medicine approach, supporting metabolic health, tissue repair and hormonal optimization by working with normal physiology rather than overriding it. Within the lens of functional medicine, they serve as targeted tools to improve cellular signaling and build long-term resilience.

People who should avoid it are those looking for a shortcut without medical supervision. It’s really important to have these discussions with a medical provider about your health goals and find what your body truly needs the most. Individuals with complex medical histories, such as cancer, uncontrolled endocrine disorders and severe cardiac disease are also poor candidates for peptide therapy. In addition, pregnant or breastfeeding patients should avoid most peptide therapies unless they’re specifically prescribed and studied for that situation.

Typically, it comes down to the medical issue a patient is dealing with, and if there’s an approved peptide therapy that aligns with that condition.

What questions should patients ask their health care provider before considering a peptide?

MM: There are a couple of areas a patient should check with their provider on before proceeding with a certain medication. You might ask your doctor if the peptide has clinical approval for your condition, if there’s evidence supporting its indication, and what labs need to be taken before and during treatment.

The bottom line is that staying informed about your options can help drive better outcomes. You should also ask what the short and long-term risks are for a specific medication, and what the signs are for seeing if it’s working or not. It’s always important to ask about how and where your medication is being sourced and manufactured. Is it coming from an FDA-registered facility? There’s a lot to consider because it’s important to be informed and confident in your care plan.

Sometimes jumping to a medication isn’t the right call. You should discuss with your doctor any lifestyle changes you can make to start optimizing your health, such as incorporating exercise, following a better diet and so on.